Clinical trial
Combination Chemotherapy With or Without Trastuzumab in Treating Women With…
NCT00004888 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00004888 |
|---|---|
| Title | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer |
| Official title | A Safety and Efficacy Study of Doxil and Taxotere ± Herceptin in Advanced Breast Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Breast Cancer, Stage IV Breast Cancer |
| Intervention type | Biological, Drug, Other |
| Interventions | pegylated liposomal doxorubicin hydrochloride, docetaxel, trastuzumab, laboratory biomarker analysis |
| Enrollment | 84 |
| Start date | Jan 1, 2001 |
| Primary completion | Apr 1, 2008 |
| Completion | May 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | May 23, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: